EUVIMEDEUVIMED entdecken
Open Access

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Neal Shore iD, Sarah M Nielsen iD, Edward D Esplin iD, Emmanuel S Antonarakis iD, Pedro C Barata iD, Tomasz M Beer iD, Himisha Beltran iD, Alan Bryce iD, Michael S Cookson, E David Crawford, Tanya B Dorff iD, Daniel J George iD und 14 weitere

JCO Oncology Practice · 2025-06 · 21 (6) · 747-753

DOI: 10.1200/op-24-00626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025-06. Verfasst von Neal Shore und 25 weiteren Autor:innen. Beteiligte Einrichtung: Carolina Urologic Research Center, Myrtle Beach, SC. Hauptthemen laut MEDLINE: Genetic Testing, Germ-Line Mutation, Prostatic Neoplasms, Standard of Care. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT has become the standard of care for many cancers such as breast, ovarian, colorectal, pancreatic, and metastatic prostate cancer, and it is imperative that patients be offered timely and equitable access to testing as it can inform patient-physician shared decision making for management of the current cancer as well as anticipatory guidance for disease progression. Additionally, GGT guides screening for and prevention of secondary malignancies for the patient and cascade testing for at-risk family members. Here, we present data supporting the notion that clinicians should offer all patients with prostate cancer the opportunity to undergo comprehensive GGT for pathogenic germline variants known to be associated with familial cancer and/or known to have implications for treatment and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGerm-Line MutationProstatic NeoplasmsStandard of CareHumansMale

Autor:innen und Institutionen

  • Carolina Urologic Research Center, Myrtle Beach, SC.
  • Labcorp Genetics Inc (formerly Invitae Corp), San Francisco, CA.
  • University of Minnesota, Masonic Cancer Center, Minneapolis, MN.
  • Case Western Reserve University, Cleveland, OH.
  • The Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Exact Sciences Corporation, Madison, WI.

ORCID-Profile: Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata, Tomasz M Beer, Himisha Beltran, Alan Bryce, Tanya B Dorff, Daniel J George, Elisabeth I Heath, Brian T Helfand, Maha Hussain, Rana R Mckay, Alicia K Morgans, Michael J Morris, Ashley E Ross, Oliver Sartor, David R Wise, Andrew J Armstrong

Förderung

  • NCI NIH HHS

Zitieren

APA

Shore, N., Nielsen, S. M., Esplin, E. D., Antonarakis, E. S., Barata, P. C., Beer, T. M., Beltran, H., Bryce, A., Cookson, M. S., Crawford, E. D., Dorff, T. B., George, D. J., Heath, E. I., Helfand, B. T., Hussain, M., Mckay, R. R., Morgans, A. K., Morris, M. J., Paller, C. J., …, & Armstrong, A. J. (2025). Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now. JCO Oncology Practice, 21(6), 747-753. https://doi.org/10.1200/op-24-00626

Vancouver

Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, et al. Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now. JCO Oncology Practice. 2025;21(6):747-753. doi:10.1200/op-24-00626

BibTeX
@article{Shore2025,
  author = {Shore, Neal and Nielsen, Sarah M and Esplin, Edward D and Antonarakis, Emmanuel S and Barata, Pedro C and Beer, Tomasz M and Beltran, Himisha and Bryce, Alan and Cookson, Michael S and Crawford, E David and Dorff, Tanya B and George, Daniel J and Heath, Elisabeth I and Helfand, Brian T and Hussain, Maha and Mckay, Rana R and Morgans, Alicia K and Morris, Michael J and Paller, Channing J and Ross, Ashley E and Sartor, Oliver and Shen, John and Sieber, Paul and Smith, Matthew R and Wise, David R and Armstrong, Andrew J},
  title = {Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now},
  journal = {JCO Oncology Practice},
  year = {2025},
  volume = {21},
  number = {6},
  pages = {747--753},
  doi = {10.1200/op-24-00626}
}
Kostenlos starten →